Read More 3 minute read Pharma Industry News Lilly’s acquisition of Disarm Therapeutics: A milestone in neurodegenerative disease treatment In a significant move to bolster its portfolio in the field of neurological disease treatments, Eli Lilly and… bypharmanewsdailyOctober 16, 2020
